Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | GLS | O94925 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 4/20 | 0.38 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9036084 | 0.87 | GLS (0.49) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL42681 | 0.87 | GLS (0.49) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL42111 | 0.87 | GLS (0.49) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL42224 | 0.81 | GLS (0.51) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL1285658 | 0.81 | GLS (0.51) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL43071 | 0.81 | GLS (0.51) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL2065162 | 0.80 | GLS (0.42) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL14665075 | 0.80 | GLS (0.44) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL2064442 | 0.80 | GLS (0.42) | NPC1LMNATP53HPGDRAB9A | |
| SCHEMBL14665079 | 0.80 | GLS (0.44) | NPC1LMNATP53HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111295373-B | Compositions and methods for treating brain injury | 阿泽凡药物公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-116327950-A | Use of a composition for the treatment of neuropsychiatric symptoms of neurodegenerative diseases | 阿泽范药品公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116139282-A | Compositions and methods for treating neurodegenerative diseases | 阿泽范药品公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-106459021-B | Compositions and methods for treating neurodegenerative diseases | 阿泽范药品公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-111295373-A | Compositions and methods for treating brain injury | 阿泽凡药物公司 | 2020-06-16 | — | — | CN | disclosed |